相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
Yelena Y. Janjigian et al.
LANCET (2021)
Phase III trial comparing XELOX regimen (oxaliplatin plus capecitabine) versus EOX regimen (epirubicin, oxaliplatin and capecitabine) as first-line treatment for advanced gastric cancer: EXELOX trial.
Weijian Guo et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Prognostic role of NLR, PLR, and LMR in patients with pulmonary embolism
Nuri Kose et al.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2020)
Diagnostic value of hematological parameters platelet to lymphocyte ratio and hemoglobin to platelet ratio in patients with colon cancer
Zuojian Hu et al.
CLINICA CHIMICA ACTA (2020)
Mean platelet volume/platelet count ratio in colorectal cancer: a retrospective clinical study
Yang-Yang Wu et al.
BMC CANCER (2019)
Platelets, Thrombo-Inflammation, and Cancer: Collaborating With the Enemy
Ana Luisa Palacios-Acedo et al.
FRONTIERS IN IMMUNOLOGY (2019)
Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients
Yann-Alexandre Vano et al.
PLOS ONE (2018)
Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab
Mariaelena Capone et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
NLR as a prognostic factor in solid tumors.
Yifei Zhang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Prognostic Value and Clinicopathologic Features of Platelet Distribution Width in Cancer: A Meta-Analysis
Wenjie Xia et al.
MEDICAL SCIENCE MONITOR (2018)
Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
Stefan Diem et al.
LUNG CANCER (2017)
CALGB 80403/ECOG 1206: A randomized phase II study of three standard chemotherapy regimens (ECF, IC, FOLFOX) plus cetuximab in metastatic esophageal and GE junction cancer.
P. C. Enzinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Platelet distribution width correlates with prognosis of non-small cell lung cancer
Ming-ming Cui et al.
SCIENTIFIC REPORTS (2017)
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E. C. Smyth et al.
ANNALS OF ONCOLOGY (2016)
Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) can risk stratify patients in transcatheter aortic-valve replacement (TAVR)
Jose F. Condado et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Doublet Versus Single Agent as Second-Line Treatment for Advanced Gastric Cancer: A Meta-Analysis of 10 Randomized Controlled Trials
Yong Zhang et al.
MEDICINE (2016)
Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells
Asaf Spiegel et al.
CANCER DISCOVERY (2016)
Tumor-infiltrating lymphocytes in breast cancer predict the response to chemotherapy and survival outcome: A meta-analysis
Ke Wang et al.
ONCOTARGET (2016)
Red cell distribution width and cancer
Martina Montagnana et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
The neutrophil-to-lymphocyte ratio (NLR) after surgery for hip fracture (HF)
Patrice Forget et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2015)
The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer
Makito Mizunuma et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2015)
Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: a randomized phase 3 trial
Sebastian Ochenduszko et al.
MEDICAL ONCOLOGY (2015)
The prognostic role of neutrophils to lymphocytes ratio and platelet count in gastric cancer: A meta-analysis
Zhang Xin-Ji et al.
INTERNATIONAL JOURNAL OF SURGERY (2015)
Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
Arnoud J. Templeton et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Neutrophil extracellular traps in cancer progression
Jonathan Cools-Lartigue et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Red cell distribution width to platelet ratio: New and promising prognostic marker in acute pancreatitis
Erdinc Cetinkaya et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma
Ji-Feng Feng et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2014)
Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy
Suee Lee et al.
BMC CANCER (2013)
Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune Cells
Theresa Placke et al.
CANCER RESEARCH (2012)
A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer
Gun Min Kim et al.
EUROPEAN JOURNAL OF CANCER (2012)
Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer
Viren Asher et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis
Francesco Montagnani et al.
GASTRIC CANCER (2011)
Elevated Preoperative Neutrophil to Lymphocyte Ratio Predicts Poor Survival Following Resection in Late Stage Gastric Cancer
Mi Ran Jung et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Mean platelet volume is a risk factor for venous thromboembolism: the Troms circle divide study
S. K. Braekkan et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth
A. McGarry Houghton et al.
NATURE MEDICINE (2010)
Weekly docetaxel monotherapy for advanced gastric or esophagogastric junction cancer - Results of a phase II study in elderly patients or patients with impaired performance status
K. Abbrederis et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study
E. van Meerten et al.
BRITISH JOURNAL OF CANCER (2007)
The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients
CA Fernández et al.
CLINICAL CANCER RESEARCH (2005)
Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia
K Kaito et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Chemotherapy in gastric cancer: a review and updated meta-analysis
KG Janunger et al.
EUROPEAN JOURNAL OF SURGERY (2002)
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population
K Imai et al.
LANCET (2000)
分享论文
